3-aminobenzamide and olaparib

3-aminobenzamide has been researched along with olaparib in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M	1
Adam, D; Chan, FK; Davarnia, P; Herdegen, T; Kabelitz, D; Lange, A; Linkermann, A; Mathieu, S; Rittger, A; Schütze, S; Sosna, J; Thon, L; Voigt, S	1
He, YJ; Liu, RH; Ning, CQ; Yu, NF	1

Reviews

1 review(s) available for 3-aminobenzamide and olaparib

Article	Year
[Research progresses of the PARP inhibitors for the treatment of cancer]. Yao xue xue bao = Acta pharmaceutica Sinica, 2013, Volume: 48, Issue:5 Topics: Animals; Antineoplastic Agents; Benzimidazoles; Breast Neoplasms; DNA Repair; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Indoles; Melanoma; Mutation; Ovarian Neoplasms; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors	2013

Article

Year

[Research progresses of the PARP inhibitors for the treatment of cancer].

Yao xue xue bao = Acta pharmaceutica Sinica, 2013, Volume: 48, Issue:5

Topics: Animals; Antineoplastic Agents; Benzimidazoles; Breast Neoplasms; DNA Repair; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Indoles; Melanoma; Mutation; Ovarian Neoplasms; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors

2013

Other Studies

2 other study(ies) available for 3-aminobenzamide and olaparib

Article	Year
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology. Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3 Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries	2023
TNF-induced necroptosis and PARP-1-mediated necrosis represent distinct routes to programmed necrotic cell death. Cellular and molecular life sciences : CMLS, 2014, Volume: 71, Issue:2 Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Benzamides; Calpain; Cathepsins; Cell Line; Ceramides; Free Radical Scavengers; Guanidines; HEK293 Cells; HeLa Cells; HT29 Cells; Humans; JNK Mitogen-Activated Protein Kinases; Jurkat Cells; MCF-7 Cells; Methyl Methanesulfonate; Mice; Necrosis; Nuclear Pore Complex Proteins; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Receptor-Interacting Protein Serine-Threonine Kinases; RNA Interference; RNA-Binding Proteins; RNA, Small Interfering; Tumor Necrosis Factor-alpha	2014

Article

Year

In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.

Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023

TNF-induced necroptosis and PARP-1-mediated necrosis represent distinct routes to programmed necrotic cell death.

Cellular and molecular life sciences : CMLS, 2014, Volume: 71, Issue:2

Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Benzamides; Calpain; Cathepsins; Cell Line; Ceramides; Free Radical Scavengers; Guanidines; HEK293 Cells; HeLa Cells; HT29 Cells; Humans; JNK Mitogen-Activated Protein Kinases; Jurkat Cells; MCF-7 Cells; Methyl Methanesulfonate; Mice; Necrosis; Nuclear Pore Complex Proteins; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Receptor-Interacting Protein Serine-Threonine Kinases; RNA Interference; RNA-Binding Proteins; RNA, Small Interfering; Tumor Necrosis Factor-alpha

2014